FDA Investigator

Zainab Y Mansaray-Storms

Latest inspection on record: Burlington, United States, February 2026 · records back to 2023

Biologics

FDA inspection record · Last updated July 12, 2026

Overview

  • 7 inspections across 7 sites are on record.
  • 0 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-02-06.

At a glance

Inspections

7

Sites

7

Observations

0

Career since

Mar 2023

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Vericel Corporation6 Feb 2026BiologicsOn file
REGENXBIO Inc4 Aug 2025Biologics
BIOMAY AG10 Dec 2024Biologics
Aspen Notre Dame de Bondeville7 Jun 2024Biologics
Humacyte Global, Inc5 Apr 2024BiologicsOn file

Sites inspected

Vericel CorporationBurlington, United States1 insp.
REGENXBIO IncRockville, United States1 insp.
BIOMAY AGVienna, Austria1 insp.
Aspen Notre Dame de BondevilleNotre-Dame-De-Bondeville, France1 insp.
Humacyte Global, IncDurham, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Jessica Araujo1 shared
Wen J Seeto1 shared
Eric A Levenson1 shared
Sarah E Underwood1 shared
Lisa T Pham1 shared
Alan G Baer1 shared
Zhong Zhao1 shared

Full investigator report

Get the verbatim findings behind Zainab Y Mansaray-Storms' inspection record

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site